Growth Metrics

Biogen (BIIB) Current Assets (2016 - 2025)

Biogen has reported Current Assets over the past 17 years, most recently at $9.0 billion for Q4 2025.

  • Quarterly results put Current Assets at $9.0 billion for Q4 2025, up 20.35% from a year ago — trailing twelve months through Dec 2025 was $9.0 billion (up 20.35% YoY), and the annual figure for FY2025 was $9.0 billion, up 20.35%.
  • Current Assets for Q4 2025 was $9.0 billion at Biogen, roughly flat from $8.9 billion in the prior quarter.
  • Over the last five years, Current Assets for BIIB hit a ceiling of $10.4 billion in Q2 2023 and a floor of $6.7 billion in Q1 2021.
  • Median Current Assets over the past 5 years was $7.9 billion (2021), compared with a mean of $8.2 billion.
  • Biggest five-year swings in Current Assets: skyrocketed 36.35% in 2022 and later tumbled 31.86% in 2024.
  • Biogen's Current Assets stood at $7.9 billion in 2021, then increased by 24.63% to $9.8 billion in 2022, then dropped by 29.94% to $6.9 billion in 2023, then increased by 8.71% to $7.5 billion in 2024, then increased by 20.35% to $9.0 billion in 2025.
  • The last three reported values for Current Assets were $9.0 billion (Q4 2025), $8.9 billion (Q3 2025), and $8.0 billion (Q2 2025) per Business Quant data.